Commonwealth Equity Services’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Commonwealth Equity Services’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-427	Closed	-$3K	–	3947
2023 Q1	$3K	Sell	427 -866	-67%	-$12.3K	﹤0.01%	3763
2022 Q4	$15K	Sell	1,293 -32	-2%	-$564	﹤0.01%	3619
2022 Q3	$28K	Sell	1,325 -338	-20%	-$9.11K	﹤0.01%	3544
2022 Q2	$40K	Sell	1,663 -100	-6%	-$3.4K	﹤0.01%	3514
2022 Q1	$87K	Buy	1,763 +83	+5%	+$4.1K	﹤0.01%	3519
2021 Q4	$117K	Sell	1,680 -3,995	-70%	-$337K	﹤0.01%	3430
2021 Q3	$529K	Sell	5,675 -10,466	-65%	-$994K	﹤0.01%	2428
2021 Q2	$1.62M	Buy	16,141 +14,799	+1,103%	+$1.44M	﹤0.01%	1574
2021 Q1	$125K	Sell	1,342 -17,695	-93%	-$1.79M	﹤0.01%	3236
2020 Q4	$1.57M	Buy	+19,037	New	+$1.62M	﹤0.01%	1365

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commonwealth Equity Services's VBIV Position: Q2 2023 in Review

Commonwealth Equity Services sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 427 shares — an estimated $3K sold.

Commonwealth Equity Services first reported a position in VBIV in Q4 2020 and held it in 10 quarters. The position peaked at $1.62M in Q2 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

Commonwealth Equity Services reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
Commonwealth Equity Services sold 427 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $3K.
Commonwealth Equity Services first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2020 and held it in 10 quarters.
Commonwealth Equity Services's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $1.62M in Q2 2021.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Commonwealth Equity Services's 13F filing for Q2 2023, filed 10 Aug 2023.